Author: Im, Kyungtaek; Kim, Jisu; Min, Hyeyoung
Title: Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection Document date: 2015_9_16
ID: u800148j_2
Snippet: Recent progress in the formulation of antiviral therapies and vaccines has helped to prevent, shorten the duration, or decrease the severity of viral infection [5e7] . Most antiviral agents are designed to target viral components, but mutations in the viral genome often result in drug resistance and immune evasion, creating a major hurdle for antiviral therapies and vaccine development [8] . In addition, the continuous emergence of new infectious.....
Document: Recent progress in the formulation of antiviral therapies and vaccines has helped to prevent, shorten the duration, or decrease the severity of viral infection [5e7] . Most antiviral agents are designed to target viral components, but mutations in the viral genome often result in drug resistance and immune evasion, creating a major hurdle for antiviral therapies and vaccine development [8] . In addition, the continuous emergence of new infectious agents such as the Ebola virus and Middle East respiratory syndrome coronavirus (MERS-CoV) necessitate the advancement of novel therapeutic approaches. Accordingly, great attention has recently been drawn to the development of antivirals with broadspectrum efficacy and immunomodulators which improve host resilience by increasing host resistance to the viral infection [9] .
Search related documents:
Co phrase search for related documents- antiviral agent and duration shorten: 1
- antiviral agent and Ebola virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- antiviral agent and host resistance: 1, 2
- antiviral agent and immune evasion: 1, 2
- antiviral agent and infectious agent: 1, 2, 3
- antiviral agent and therapeutic approach: 1, 2, 3, 4, 5
- antiviral agent and vaccine antiviral therapy: 1
- antiviral agent and vaccine development: 1, 2, 3
- antiviral agent and viral component: 1
- antiviral agent and viral component target: 1
- antiviral agent and viral genome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- antiviral agent and viral genome mutation: 1
- antiviral agent and viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- antiviral development and continuous emergence: 1, 2
- antiviral development and drug resistance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- antiviral development and Ebola virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- antiviral development and great attention: 1
- antiviral development and host resistance: 1, 2, 3, 4, 5, 6, 7
- antiviral development and immune evasion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Co phrase search for related documents, hyperlinks ordered by date